Abstract
About this talk
Introduction: Fuchs’ endothelial corneal dystrophy (FECD) is a progressive blinding disease characterised by loss and dysfunction of corneal endothelial cells required to maintain corneal clarity. Advanced disease requires corneal transplantation, highlighting the need for non-surgical strategies to preserve corneal endothelial function. Our previous single-nucleus RNA sequencing identified increased fibroblast growth factor 7 (FGF7) in FECD endothelium, but the significance of this response remains unknown.
Objectives: This study aimed to determine the role of increased FGF7 in human corneal endothelial cells and its relevance to FECD.
Methods: FGF7 localisation was assessed by immunocytochemistry in endothelium from healthy donors and patients with late-stage FECD (n=3/group). Immortalised human corneal endothelial HCEC-B4G12 cells were treated with recombinant FGF7 (rFGF7) or transforming growth factor-β1 (rTGF-β1), an inducer of endothelial-to-mesenchymal transition (EndMT). EndMT, endothelial-associated markers and NRF2-associated stress responses were assessed by RT-qPCR, western blot and immunocytochemistry. Cell migration and proliferation were assessed by scratch wound-healing and WST-1 assays, respectively. Ultraviolet-A (UVA) irradiation was used to model FECD-associated oxidative stress in vitro.
Results: FGF7 was detected in a subset of cells within late-stage FECD endothelium that retained functional ion-pump ATP1A1, but was not detected in healthy endothelium. Unlike rTGF-β1, rFGF7 did not induce a coordinated EndMT response or alter cell migration or proliferation. rFGF7 increased endothelial-associated markers ALCAM/CD166, ZO-1 and ATP1A1. rFGF7 also increased NRF2, a key regulator of cellular stress responses, and its downstream target NQO1. NRF2 was significantly increased following FGF7 treatment (P<0.05). UVA-induced oxidative stress increased endogenous FGF7 expression >1.5-fold at 24 h (P<0.01).
Conclusion: These findings suggest FGF7 acts as a stress-responsive regulator that promotes endothelial phenotype and function without inducing pathological EndMT, potentially through an NRF2-mediated response. Targeting FGF7 signalling may offer a novel approach to preserve endothelial function and provide a foundation for developing non-surgical therapeutic strategies for FECD.
Keywords: FGF7, Fuchs' endothelial corneal dystrophy, Endothelial-to-mesenchymal transition, NRF2, Oxidative stress
Speaker
About the speaker

